gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Disease Models, Animal in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (27.59) | 29.6817 |
| 2010's | 20 (68.97) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Black, KL; Ding, H; Galstyan, A; Grodzinski, ZB; Holler, E; Israel, LL; Ljubimova, JY; Patil, R; Shatalova, ES; Wagner, S | 1 |
| Andia, ME; Botnar, RM; Lacerda, S; Lavin, B; Phinikaridou, A; Saha, P; Smith, A | 1 |
| Baudimont, F; Corot, C; Fretellier, N; Granottier, A; Grindel, AL; Idée, JM; Rasschaert, M; Robert, P | 1 |
| Hu, H; Pitek, AS; Shukla, S; Steinmetz, NF | 1 |
| Caravan, P; Erstad, DJ; Fuchs, BC; Gale, EM; Jordan, VC; Ramsay, IA; Sojoodi, M; Tanabe, KK | 1 |
| Allen, JS; Caruthers, SD; Hu, G; Lanza, GM; Schmieder, AH; Wickline, SA; Williams, TA; Winter, PM; Zhang, H | 1 |
| Beckmann, N; Cannet, C; Debon, C; Dunbar, A; Egger, C; Gérard, C; Li, J; Stohler, N; Tigani, B | 1 |
| Bajd, F; Blagus, T; Čemažar, M; Kranjc, M; Markelc, B; Miklavčič, D; Serša, I | 1 |
| Bluemke, DA; Davies-Venn, C; Kim, H; Kim, I; Kim, JS; Lee, SJ; Paik, CH; Yang, BY; Yao, Z | 1 |
| Kameo, S; Kartamihardja, AA; Koyama, H; Nakajima, T; Tsushima, Y | 1 |
| Aletras, AH; Arheden, H; Carlsson, M; Engblom, H; Erlinge, D; Jablonowski, R; Kanski, M; Koul, S; Nordlund, D | 1 |
| Blum, A; Corot, C; Gillet, P; Goebel, JC; Lapicque, F; Loeuille, D; Netter, P; Robert, P; Walter, F; Watrin-Pinzano, A | 1 |
| Carlsson, M; Dicks, D; Martin, A; Saeed, M; Saloner, D | 1 |
| Berdeaux, A; Couvreur, N; Deux, JF; Garot, J; Ghaleh, B; Guéret, P; Mansencal, N; Rahmouni, A; Rienzo, M; Tissier, R | 1 |
| Bazeli, R; Corot, C; Coutard, M; Duport, BD; Laissy, JP; Lancelot, E; Letourneur, D; Michel, JB; Serfaty, JM | 1 |
| Barbier, EL; Bouchet, A; Coquery, N; Le Duc, G; Lemasson, B; Maisin, C; Rémy, C; Robert, P; Serduc, R; Troprès, I | 1 |
| Beissner, RS; Morelli, JN; Runge, VM; Tweedle, M; Williams, JM | 1 |
| Haubner, BJ; Klug, G; Kremser, C; Loizides, A; Mayr, A; Metzler, B; Müller, S; Pachinger, O; Schocke, M; Voelkl, JG | 1 |
| Bankstahl, JP; Bankstahl, M; Ding, XQ; Kuntner, C; Langer, O; Löscher, W; Meier, M; Müller, M; Stanek, J; Wanek, T | 1 |
| Pyykkö, I; Ramadan, UA; Yoshida, T; Zou, J | 1 |
| Brady-Kalnay, SM; Burden-Gulley, SM; Gulani, V; Li, W; Lindner, D; Lu, ZR; Tan, M; Wu, X | 1 |
| Agudelo, CA; Hurtado, AF; Iida, H; Ose, T; Tachibana, Y; Yamaoka, T | 1 |
| Berr, SS; Fujiwara, N; Hagspiel, KD; Keilholz, SD; Mai, VM | 1 |
| Bara, J; Corot, C; Debatin, JF; Herborn, CU; Laclédère, C; Robert, P; Ruehm, SG; Violas, X; Yang, F | 1 |
| Delatour, B; Dhenain, M; Volk, A; Walczak, C | 1 |
| Barbier, EL; Grillon, E; Montigon, O; Provent, P; Rémy, C; Segebarth, C | 1 |
| Apodaca-Torrez, FR; Artigiani Neto, R; Benvenuto, RB; Farah, JF; Goldenberg, A; Lobo, EJ; Montero, EF; Schraibman, V; Triviño, T | 1 |
| Croisille, P; Higgins, CB; Mewton, N; Revel, D; Saeed, M; Weber, O | 1 |
| Bazot, MJ; Bigot, JM; Bonneau, M; Boudghene, F; Farres, MT; Le Blanche, AF; Levy, B; Wassef, M | 1 |
29 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Disease Models, Animal
| Article | Year |
|---|---|
Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Female; Glioblastoma; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Mice, Nude; Nanostructures; Organometallic Compounds; Xenograft Model Antitumor Assays | 2020 |
Tropoelastin: A novel marker for plaque progression and instability.
Topics: Animals; Aortic Diseases; Atherosclerosis; Biomarkers; Carotid Artery Diseases; Contrast Media; Disease Models, Animal; Disease Progression; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; Molecular Imaging; Oligopeptides; Organometallic Compounds; Plaque, Atherosclerotic; Predictive Value of Tests; Rabbits; Rupture, Spontaneous; Tropoelastin | 2018 |
Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats.
Topics: Age Factors; Aging; Animals; Bone and Bones; Brain; Contrast Media; Disease Models, Animal; Female; Gadolinium DTPA; Heterocyclic Compounds; Male; Microscopy, Fluorescence; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Spectrophotometry, Atomic | 2019 |
Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles.
Topics: Albumins; Animals; Biocompatible Materials; Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Disease Models, Animal; Drug Delivery Systems; Female; Heterocyclic Compounds; Humans; Hydrogen-Ion Concentration; Light; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Organometallic Compounds; Prostatic Neoplasms; Scattering, Radiation; Theranostic Nanomedicine; Tobacco Mosaic Virus | 2018 |
Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A.
Topics: Animals; Breast Neoplasms; Contrast Media; Diamines; Disease Models, Animal; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Manganese Compounds; Mice; Mice, Inbred BALB C; Organometallic Compounds; Picolinic Acids; Tissue Distribution | 2019 |
Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticles.
Topics: Analysis of Variance; Animals; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Disease Progression; Gadolinium DTPA; Heterocyclic Compounds; Hindlimb; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Least-Squares Analysis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Neovascularization, Pathologic; Organometallic Compounds; Rabbits; Statistics, Nonparametric | 2013 |
Adriamycin-induced nephropathy in rats: functional and cellular effects characterized by MRI.
Topics: Animals; Contrast Media; Disease Models, Animal; Doxorubicin; Ferric Compounds; Heterocyclic Compounds; Image Enhancement; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Male; Organometallic Compounds; Rats; Rats, Wistar; T-Lymphocytes, Regulatory | 2015 |
In situ monitoring of electric field distribution in mouse tumor during electroporation.
Topics: Animals; Contrast Media; Disease Models, Animal; Electroporation; Feasibility Studies; Fibrosarcoma; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Mice; Organometallic Compounds | 2015 |
64Cu-DOTA as a surrogate positron analog of Gd-DOTA for cardiac fibrosis detection with PET: pharmacokinetic study in a rat model of chronic MI.
Topics: Animals; Autoradiography; Chronic Disease; Copper Radioisotopes; Disease Models, Animal; Drug Stability; Electrons; Fibrosis; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Myocardial Infarction; Myocardium; Organometallic Compounds; Positron-Emission Tomography; Rats | 2016 |
Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model.
Topics: Animals; Brain; Contrast Media; Disease Models, Animal; Female; Gadolinium DTPA; Heterocyclic Compounds; Mice; Organometallic Compounds; Renal Insufficiency; Spectrophotometry, Atomic | 2016 |
Experimental validation of contrast-enhanced SSFP cine CMR for quantification of myocardium at risk in acute myocardial infarction.
Topics: Animals; Contrast Media; Disease Models, Animal; Heterocyclic Compounds; Magnetic Resonance Imaging, Cine; Myocardial Infarction; Myocardial Perfusion Imaging; Myocardium; Organometallic Compounds; Predictive Value of Tests; Reproducibility of Results; Risk Assessment; Risk Factors; Sus scrofa; Tomography, Emission-Computed, Single-Photon | 2017 |
Quantitative dynamic contrast enhanced MRI of experimental synovitis in the rabbit knee: comparison of macromolecular blood pool agents vs. Gadolinium-DOTA.
Topics: Animals; Contrast Media; Disease Models, Animal; Heterocyclic Compounds; Image Enhancement; Knee Joint; Magnetic Resonance Imaging; Male; Organometallic Compounds; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Synovitis | 2008 |
Percutaneous transendocardial VEGF gene therapy: MRI guided delivery and characterization of 3D myocardial strain.
Topics: Animals; Contrast Media; Disease Models, Animal; Dogs; Endocardium; Genetic Therapy; Heterocyclic Compounds; Imaging, Three-Dimensional; Magnetic Resonance Imaging, Cine; Myocardial Infarction; Neovascularization, Physiologic; Organometallic Compounds; Vascular Endothelial Growth Factor A; Ventricular Function, Left | 2010 |
Relation of the ischaemic substrate to left ventricular remodelling by cardiac magnetic resonance at 1.5 T in rabbits.
Topics: Animals; Chi-Square Distribution; Contrast Media; Disease Models, Animal; Heterocyclic Compounds; Linear Models; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Male; Myocardial Infarction; Myocardial Reperfusion; Organometallic Compounds; Rabbits; Ventricular Remodeling | 2010 |
In vivo evaluation of a new magnetic resonance imaging contrast agent (P947) to target matrix metalloproteinases in expanding experimental abdominal aortic aneurysms.
Topics: Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Contrast Media; Disease Models, Animal; Heterocyclic Compounds; Magnetic Resonance Imaging; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Molecular Imaging; Organometallic Compounds; Pancreatic Elastase; Radionuclide Imaging; Rats; Rats, Wistar; Statistics, Nonparametric | 2010 |
Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media.
Topics: Analysis of Variance; Animals; Area Under Curve; Benzenesulfonates; Blood-Brain Barrier; Brain Neoplasms; Contrast Media; Disease Models, Animal; Glioma; Heterocyclic Compounds; Macromolecular Substances; Magnetic Resonance Imaging; Male; Neovascularization, Pathologic; Niacinamide; Organometallic Compounds; Phenylurea Compounds; Pyridines; Random Allocation; Rats; Sorafenib | 2010 |
Evaluation of a fibrin-binding gadolinium chelate peptide tetramer in a brain glioma model.
Topics: Animals; Area Under Curve; Brain Neoplasms; Contrast Media; Disease Models, Animal; Fibrin; Fluorescent Antibody Technique, Direct; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Organometallic Compounds; Rats; Rats, Inbred F344 | 2011 |
Cardiac imaging using clinical 1.5 t MRI scanners in a murine ischemia/reperfusion model.
Topics: Analysis of Variance; Animals; Cardiac Imaging Techniques; Disease Models, Animal; Echocardiography; Heart Ventricles; Heterocyclic Compounds; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Myocardial Infarction; Organometallic Compounds; Phenotype; Reperfusion Injury | 2011 |
A novel positron emission tomography imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood-brain barrier.
Topics: Analysis of Variance; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Calcium Channel Blockers; Carbon Isotopes; Computer Simulation; Disease Models, Animal; Female; Gene Expression Regulation; Heterocyclic Compounds; Magnetic Resonance Imaging; Models, Chemical; Organometallic Compounds; Pilocarpine; Positron-Emission Tomography; Quinolines; Rats; Rats, Sprague-Dawley; Scopolamine; Seizures; Time Factors; Verapamil | 2011 |
Dynamic enhancement of the rat inner ear after ultra-small-volume administration of Gd-DOTA to the medial wall of the middle ear cavity.
Topics: Animals; Contrast Media; Disease Models, Animal; Ear Diseases; Ear, Inner; Ear, Middle; Gadolinium; Heterocyclic Compounds; Injections; Magnetic Resonance Imaging; Male; Organometallic Compounds; Rats; Rats, Wistar; Reproducibility of Results | 2011 |
MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.
Topics: Animals; Carbocyanines; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Fibrin; Fibronectins; Fluorescent Dyes; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Molecular Imaging; Nanoparticles; Organometallic Compounds; Peptides, Cyclic; Prostatic Neoplasms; Transplantation, Heterologous | 2012 |
The use of magnetic resonance cell tracking to monitor endothelial progenitor cells in a rat hindlimb ischemic model.
Topics: Animals; Cell Movement; Cell Tracking; Dextrans; Disease Models, Animal; Endothelial Cells; Gadolinium; Heterocyclic Compounds; Hindlimb; Imaging, Three-Dimensional; Ischemia; Magnetic Resonance Spectroscopy; Male; Organometallic Compounds; Rats; Rats, Inbred F344; Regional Blood Flow; Stem Cell Transplantation; Stem Cells; Wound Healing | 2012 |
Comparison of first-pass Gd-DOTA and FAIRER MR perfusion imaging in a rabbit model of pulmonary embolism.
Topics: Animals; Contrast Media; Disease Models, Animal; Heterocyclic Compounds; Magnetic Resonance Imaging; Organometallic Compounds; Pulmonary Circulation; Pulmonary Embolism; Rabbits; Spin Labels | 2002 |
Dark lumen magnetic resonance colonography in a rodent polyp model: initial experience and demonstration of feasibility.
Topics: Animals; Colonic Polyps; Contrast Media; Disease Models, Animal; Feasibility Studies; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Organometallic Compounds; Radiography; Rats; Rats, Wistar | 2004 |
Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Animals; Disease Models, Animal; Female; Heterocyclic Compounds; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Transgenic; Organometallic Compounds; Plaque, Amyloid; Staining and Labeling | 2006 |
Blood-brain barrier permeability to manganese and to Gd-DOTA in a rat model of transient cerebral ischaemia.
Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Cerebral Angiography; Contrast Media; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Heterocyclic Compounds; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Manganese; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; Time Factors | 2008 |
Evaluation of the effects of noniodinized and iodinized ionic contrast media and gadoteric acid in acute necrotizing pancreatitis: experimental study in rabbits.
Topics: Animals; Contrast Media; Disease Models, Animal; Heterocyclic Compounds; Injections, Intravenous; Iohexol; Iothalamate Meglumine; Laser-Doppler Flowmetry; Necrosis; Organometallic Compounds; Osmolar Concentration; Pancreas; Pancreatitis, Acute Necrotizing; Rabbits; Regional Blood Flow; Taurocholic Acid; Time Factors | 2007 |
Left ventricular postmyocardial infarction remodeling studied by combining MR-tagging with delayed MR contrast enhancement.
Topics: Analysis of Variance; Animals; Contrast Media; Disease Models, Animal; Heterocyclic Compounds; Magnetic Resonance Imaging, Cine; Myocardial Infarction; Organometallic Compounds; Swine; Ventricular Remodeling | 2008 |
Evaluation of renal arteries with use of gadoterate meglumine-, CO(2)-, and iodixanol-enhanced DSA measurements versus histomorphometry in renal artery restenosis in rabbits.
Topics: Angiography, Digital Subtraction; Animals; Carbon Dioxide; Contrast Media; Disease Models, Animal; Heterocyclic Compounds; Male; Meglumine; Organometallic Compounds; Rabbits; Renal Artery; Renal Artery Obstruction; Triiodobenzoic Acids | 2001 |